ABI s Revenues Rise 4 Percent in Q2; DNA Sequencing Revs Expected to Fall in 2006 | GenomeWeb

Applied Biosystems today reported that its second-quarter revenues increased 4 percent year over year to $482 million, but excluding the impact of foreign currency, sales growth would have been 6 percent for the quarter.

DNA sequencing revenues fell 1 percent to $140.7 million year over year, and the firm is predicting a continued decline in sales of those products over the rest of the year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.